These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31668951)

  • 1. Corrigendum to 'Anti-restenosis Treatment With Drug-Eluting or Covered Stents in Femoropopliteal Arterial Occlusive Disease: Evidence From a Comprehensive Network Meta-analysis' [European Journal of Vascular & Endovascular Surgery 58/1 (2019) 61-74].
    He R; Ye Y; Li Z; Jiang Y; Li Y; Liu Y; Wang K; Yao C
    Eur J Vasc Endovasc Surg; 2020 Jan; 59(1):158. PubMed ID: 31668951
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolving modalities for femoropopliteal interventions.
    Ansel GM; Lumsden AB
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
    Jongsma H; van Mierlo-van den Broek P; Imani F; van den Heuvel D; de Vries JPM; Fioole B
    J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug eluting balloons.
    Diehm NA; Hoppe H; Do DD
    Tech Vasc Interv Radiol; 2010 Mar; 13(1):59-63. PubMed ID: 20123434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents in peripheral vascular disease: eliminating restenosis.
    Ellozy SH; Carroccio A
    Mt Sinai J Med; 2003 Nov; 70(6):417-9. PubMed ID: 14647877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions.
    Antonopoulos CN; Mylonas SN; Moulakakis KG; Sergentanis TN; Sfyroeras GS; Lazaris AM; Kakisis JD; Vasdekis SN
    J Vasc Surg; 2017 Jan; 65(1):234-245.e11. PubMed ID: 27865639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis.
    Varetto G; Gibello L; Boero M; Frola E; Peretti T; Spalla F; Verzini F; Rispoli P
    J Cardiovasc Surg (Torino); 2019 Oct; 60(5):546-556. PubMed ID: 31527577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K; Ullery BW; Kret MR; Lee JT
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of endovascular treatment strategies on in-stent restenosis of femoropopliteal artery lesions].
    Fu WG; Yue JN
    Zhonghua Wai Ke Za Zhi; 2016 Aug; 54(8):586-90. PubMed ID: 27502131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly approved devices for endovascular treatment of femoropopliteal disease: a review of clinical evidence.
    Giannopoulos S; Armstrong EJ
    Expert Rev Cardiovasc Ther; 2019 Oct; 17(10):729-740. PubMed ID: 31575289
    [No Abstract]   [Full Text] [Related]  

  • 13. Cryoplasty for the prevention of arterial restenosis.
    Wildgruber MG; Berger HJ
    Cardiovasc Intervent Radiol; 2008; 31(6):1050-8. PubMed ID: 18535858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midterm Patency After Femoropopliteal Interventions: A Comparison of Standard and Interwoven Nitinol Stents and Drug-Coated Balloons in a Single-Center, Propensity Score-Matched Analysis.
    Steiner S; Schmidt A; Bausback Y; Piorkowski M; Werner M; Yahiaoui-Doktor M; Banning-Eichenseer U; Scheinert D
    J Endovasc Ther; 2016 Apr; 23(2):347-55. PubMed ID: 26848131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endovascular approach for in-stent restenosis in femoropopliteal disease.
    Cannavale A; Tsetis D; Krokidis M
    Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):391-401. PubMed ID: 25761905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current state of surgical bypass versus drug eluting stents for long femoropopliteal occlusive lesions.
    Yanagisawa W; Gomes ML; Menting TP; De Loose KR; Varcoe RL
    J Cardiovasc Surg (Torino); 2019 Aug; 60(4):450-455. PubMed ID: 31062570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
    Dake MD; Ansel GM; Jaff MR; Ohki T; Saxon RR; Smouse HB; Machan LS; Snyder SA; O'Leary EE; Ragheb AO; Zeller T;
    Circulation; 2016 Apr; 133(15):1472-83; discussion 1483. PubMed ID: 26969758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Drug-Eluting Stent with Bare-Metal Stent Implantation in Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis.
    Ding Y; Zhou M; Wang Y; Cai L; Shi Z
    Ann Vasc Surg; 2018 Jul; 50():96-105. PubMed ID: 29514049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studies.
    Langwieser N; Buyer D; Schuster T; Haller B; Laugwitz KL; Ibrahim T
    J Endovasc Ther; 2014 Oct; 21(5):683-92. PubMed ID: 25290797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral drug-eluting technology.
    Franzone A; Stabile E; Trimarco B; Esposito G
    Cardiol Clin; 2015 Feb; 33(1):151-62. PubMed ID: 25439337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.